Sometimes, good policy is a question of good timing. The human papillomavirus vaccine, which Texas mandated for its sixth-grade girls last week, and which state legislatures around the country have been considering, is a good case in point.
By all accounts, the new vaccine against cervical cancer, developed by Merck...
Posted September 30, 2007 | 21:02:21 (EST)